4//SEC Filing
Duncan Barbara Gayle 4
Accession 0001209191-24-003958
CIK 0001636651other
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 5:54 PM ET
Size
5.4 KB
Accession
0001209191-24-003958
Insider Transaction Report
Form 4
Duncan Barbara Gayle
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-02-22+30,000→ 30,000 totalExercise: $3.68Exp: 2034-02-21→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]The option will vest in full on February 22, 2025, subject to the Reporting Person's continuous service through such vesting date.
Documents
Issuer
Ovid Therapeutics Inc.
CIK 0001636651
Entity typeother
Related Parties
1- filerCIK 0001353128
Filing Metadata
- Form type
- 4
- Filed
- Feb 25, 7:00 PM ET
- Accepted
- Feb 26, 5:54 PM ET
- Size
- 5.4 KB